New Delhi, Jul 8 (UNI) Dr Reddy's Laboratories Ltd, a leading pharmaceutical firm, today said it has signed an agreement with the US-based Albemarle Corporation for marketing active pharmaceutical ingredient 'ibuprofen' to its global clients.
Under the agreement, Dr Reddy's, a non-exclusive distributor of Albemarle's bulk 'ibuprofen' active pharmaceutical ingredients (API), will market, sell and distribute the API to its global clients.
In addition, Albemarle will also supply Dr Reddy's a substantial quantity of its ibuprofen API requirements for use in the company's generic ibuprofen tablets.
Albemarle is a global manufacturer of the anti-inflammatory agent ibuprofen and other APIs.
UNI SR SBA UCS1939